Ovarian Remnant Syndrome: Symptoms, Diagnosis, and Treatment

When you’ve had ovaries removed—why are you still having symptoms?

If you’ve had an oophorectomy (one ovary removed) or a bilateral salpingo-oophorectomy (both ovaries and tubes removed), it’s reasonable to assume ovarian problems are “off the table.” So it can feel shocking to develop pelvic pain after oophorectomy, or be told imaging shows an “adnexal” mass, cyst, or something that looks ovarian.

Multiple recent case reports and clinical reviews describe a rare but real explanation: ovarian remnant syndrome. This is not the same as “ovaries growing back.” Instead, it means a small amount of ovarian tissue was unintentionally left behind and later becomes visible or symptomatic.

Because ovarian remnant syndrome is uncommon and symptoms are often nonspecific, diagnosis can be delayed. The good news: understanding what it is, who is at risk, and how it’s evaluated can help you and your clinician make a clearer plan.

What is ovarian remnant syndrome (and can ovaries grow back)?

Patients often search: “can ovaries grow back?” The evidence described across reports suggests the accurate answer is: ovaries don’t regrow, but tiny remnants can remain after surgery and later enlarge or form cysts.

Clinically, ovarian remnant syndrome (ORS) is generally defined as histologically confirmed ovarian tissue in someone who previously had an ovary (or ovaries) removed. In other words, ORS is confirmed when tissue removed at a later surgery is examined under the microscope and proven to be ovarian in origin.

ORS most often happens after difficult surgeries—not because a surgeon was careless, but because scar tissue and distorted anatomy can make it challenging to safely separate the ovary from nearby structures.

Who is at higher risk—especially with endometriosis or adenomyosis surgery?

Across the published cases and review literature, a consistent theme is that ORS is more likely when the initial oophorectomy was complicated by dense adhesions (scar tissue), which can occur with:

• Endometriosis (a common reason for adhesions and complex pelvic anatomy)
• Prior pelvic/abdominal surgery
• Pelvic inflammatory disease or severe inflammation

This matters for people with endometriosis and adenomyosis because ovary removal is sometimes performed alongside hysterectomy or other procedures to control symptoms, and those surgeries can be technically demanding when adhesions tether the ovary to the pelvic sidewall, bowel, bladder, or ureter. In that setting, leaving microscopic ovarian tissue behind can be a risk—even if the ovary is “removed” to the best of a surgeon’s ability while prioritizing safety.

Ovarian remnant syndrome symptoms: what does it feel like?

Ovarian remnant syndrome symptoms can look like many other pelvic conditions, which is one reason it’s often “unsuspected.” The most common presentations described across reports include:

• Chronic pelvic pain (sometimes one-sided, sometimes deep/aching)
• A new pelvic mass or cyst found on imaging
• Pain with sex (dyspareunia) or pelvic pressure
• Urinary or bowel pressure symptoms depending on where the remnant is located

Less commonly—but importantly—ORS-related tissue can be located near or attached to bowel. One published case described an unusual presentation with intestinal obstruction, where a small nodule near the affected bowel was removed and later proven on pathology to be ovarian tissue. That’s rare, but it highlights why persistent or escalating symptoms deserve a careful workup.

How long after surgery can ORS show up?

One of the most surprising (and validating) findings across cases is timing: ORS can present many years—even decades—after surgery.

Reports describe pelvic masses appearing 19 years after a unilateral salpingo-oophorectomy and 30 years after hysterectomy with bilateral salpingo-oophorectomy. That long time frame is one reason patients are sometimes told, “It can’t be ovarian”—when, in rare situations, it actually can be related to residual ovarian tissue.

How is ovarian remnant syndrome diagnosed?

1) History and exam (the “pattern recognition” piece)

Diagnosis often starts with a clinician connecting the dots: prior oophorectomy + new pelvic pain/mass + risk factors like endometriosis/adhesions. A key challenge is that many clinicians (and patients) understandably don’t think of ORS early, especially years after surgery.

2) Imaging: ultrasound and CT/MRI can help—but may not be definitive

Imaging can raise suspicion, but several reports emphasize that imaging may be misleading in both directions:

• A mass may be seen and mistaken for something else (for example, a uterine fibroid/leiomyoma or adenomyosis-related mass).
• A test may be negative and still miss the problem. In one case, transvaginal ultrasound was negative, while transabdominal ultrasound and CT detected a multilocular cystic lesion among bowel loops—meaning the “right” imaging approach can depend on where the remnant sits.

In practice, your clinician may use a combination of:

• Transvaginal ultrasound (TVUS)
• Transabdominal ultrasound
• CT or MRI when anatomy is complex or the mass is higher in the abdomen

3) Blood tests (tumor markers): sometimes helpful, often nonspecific

Patients commonly worry about cancer when a pelvic mass is found—especially if CA-125 is elevated. Evidence from ORS cases shows that tumor markers may be:

• Normal, even with a mass
• Mildly elevated for benign reasons (including inflammation/adhesions or benign ovarian-type tumors)

In one case, CA-125 rose and later normalized with treatment after a malignancy was found; in another, CA-125 elevation occurred in the setting of a benign ovarian-type tumor arising in remnant tissue. The takeaway is that tumor markers alone usually can’t rule cancer in or out.

4) The only “final” diagnosis: pathology

Across multiple reports, the consistent point is: ORS is confirmed by histology—microscopic examination of excised tissue. Some patients also have a frozen section done during surgery (a rapid pathology review) if there is concern for malignancy, which can change the surgical plan in real time.

Is ovarian remnant syndrome dangerous?

Patients often search “ovarian remnant syndrome dangerous”. Most of the time, ORS is dangerous in the sense of being painful, disruptive, and anxiety-provoking, not because it is commonly life-threatening.

That said, the published literature includes rare but serious possibilities:

1) Complications from location/adhesions

Remnant tissue can be embedded in or tightly stuck to bowel, bladder, or ureter. This can cause pressure symptoms, and in rare circumstances contribute to obstruction or require complex surgery.

2) Rare malignant transformation

Several reports describe cancers arising in presumed ovarian remnants years after oophorectomy, including endometrioid carcinoma and clear cell carcinoma. These are case reports, so they do not tell us how often this happens—only that it can happen.

A practical way to hold this information is:

• The absolute risk appears low, but
• A new, enlarging, or complex mass after oophorectomy should be evaluated seriously, and
• When imaging/labs cannot confidently exclude malignancy, surgical removal for diagnosis and treatment may be recommended.

Treatment options: what can you do if ORS is suspected?

Treatment depends on your symptoms, imaging features, cancer concern, and overall health.

Watchful waiting (select cases)

If symptoms are mild and imaging looks stable and benign, a clinician may recommend monitoring with repeat imaging. This approach is most appropriate when the risk of surgery is high and the mass looks low-risk.

Medical (hormonal) options

Because remnants can be hormonally responsive, some clinicians may consider hormonal suppression (similar to endometriosis management) to reduce stimulation of ovarian tissue. The available case-based evidence is much stronger for diagnosis/surgery than for medication success, but in real-world care, medical therapy may be discussed when:

• Pain is present without a clearly removable target, or
• You need symptom control while planning next steps.

Surgical excision (the main definitive treatment)

When ORS causes significant pain, a growing mass, concerning imaging, or persistent uncertainty, surgical removal is usually the definitive option—because it both treats the problem and provides tissue for diagnosis.

Important themes from reported cases:

• Surgery can be technically complex, especially with endometriosis-related adhesions.
• The remnant may be near bowel; some cases required multi-disciplinary planning or bowel involvement.
• Intraoperative pathology (frozen section) may be used if cancer is a concern, potentially expanding the procedure to a staging-type surgery.

What to expect if you’re being worked up for ORS

Timeline-wise, many patients go through steps:

1. Symptom evaluation and pelvic exam
2. Targeted imaging (sometimes more than one kind)
3. Labs (including tumor markers in some cases)
4. Referral to a surgeon experienced in complex pelvic surgery (often minimally invasive gynecologic surgery specialists, sometimes gynecologic oncology if malignancy risk is higher)
5. Surgery when indicated, with pathology confirmation

The key emotional reality is that this workup can feel slow—especially when pain is ongoing—but careful planning matters because the safest surgery depends on understanding adhesions and nearby structures.

Practical takeaways (and questions to ask your doctor)

• “Given my history of endometriosis/adhesions, could ovarian remnant syndrome explain my symptoms or this mass?”
• “What imaging is best in my case—should we add transabdominal ultrasound, CT, or MRI if TVUS is negative or unclear?”
• “If my CA-125 (or other markers) is abnormal, what else could explain that besides cancer?”
• “At what point would you recommend surgery, and would this be better handled by a surgeon experienced in complex adhesiolysis or a gynecologic oncologist?”
• “If surgery is planned, what is the plan to protect my bowel/bladder/ureter, and is a multidisciplinary team needed?”

What we still don’t know (and why individual experiences vary)

The current evidence base discussed here is largely case reports and small clinical series, which are valuable for recognizing rare conditions but cannot provide precise rates (for example, how often ORS occurs, or the true risk of cancer in remnants).

We also don’t yet have strong comparative research on:

• Which medical therapies work best for symptom control in confirmed ORS
• The best standardized imaging pathway when ORS is suspected
• Predictors of who will do well with monitoring versus who benefits from earlier surgery

Because ORS is tied so closely to surgical difficulty and individual anatomy, results vary widely. If you’re dealing with pelvic pain after oophorectomy or a new pelvic cyst and you feel like “this shouldn’t be happening,” ORS is one of the important—though uncommon—possibilities to put on the list, especially after complex endometriosis surgery.